Berryman DE, Glad CAM, List EO, Johannsson G
3.4 What Do the Guidelines Say
GLP-1 meds curb your appetite by slowing digestion, and that same slowdown leaves stool hard, dry, and stuck
This difference stems from the dual mechanism: by engaging both GLP-1 and GIP pathways, tirzepatide may offer enhanced metabolic benefits for some individuals
14.4 Effects in Documented Coronary Artery Disease In PREVENT, 825 patients with angiographically documented coronary artery disease were randomized to amlodipine (5 to 10 mg once daily) or placebo and followed for 3 years
The results demonstrated that the combined regimen significantly improved tinnitus-related scores and TCM syndrome integrals, enhanced hemorheological conditions, and reduced oxidative stress and inflammatory markers compared to cobamamide alone